Published in Circulation on March 01, 1991
Acute Chest Pain Treatment and Evaluation (ACTION) Study | NCT00434564
Troponin: the biomarker of choice for the detection of cardiac injury. CMAJ (2005) 2.23
Prospective study of the role of cardiac troponin T in patients admitted with unstable angina. BMJ (1996) 1.74
Cardiac troponin level elevations not related to acute coronary syndromes. Nat Rev Cardiol (2013) 1.71
Cardiac myosin-binding protein C: a potential early biomarker of myocardial injury. Basic Res Cardiol (2015) 1.52
Differential diagnosis of elevated troponins. Heart (2006) 1.40
Cardiac myosin binding protein-C is a potential diagnostic biomarker for myocardial infarction. J Mol Cell Cardiol (2011) 1.27
Troponin T concentrations 72 hours after myocardial infarction as a serological estimate of infarct size. Heart (2002) 1.19
Release of cardiac troponin I from viable cardiomyocytes is mediated by integrin stimulation. Pflugers Arch (2007) 1.08
Troponin T measurement after myocardial infarction can identify left ventricular ejection of less than 40%. Heart (1998) 0.99
Assessment of reperfusion of the infarct zone after acute myocardial infarction by serial cardiac troponin T measurements in serum. Br Heart J (1994) 0.94
A method for inferring medical diagnoses from patient similarities. BMC Med (2013) 0.93
Biochemical markers of myocyte injury in heart failure. Heart (2004) 0.90
Cardiac magnetic resonance and computed tomography angiography for clinical imaging of stable coronary artery disease. Diagnostic classification and risk stratification. Front Physiol (2014) 0.89
Postmortem pericardial natriuretic peptides as markers of cardiac function in medico-legal autopsies. Int J Legal Med (2006) 0.88
Cardiac troponins and autoimmunity: their role in the pathogenesis of myocarditis and of heart failure. Clin Immunol (2009) 0.88
Troponin T release after heart transplantation. Br Heart J (1993) 0.86
Serum protein profiles predict coronary artery disease in symptomatic patients referred for coronary angiography. BMC Med (2012) 0.86
Troponin T cross-linking in human apoptotic cardiomyocytes. Am J Pathol (1997) 0.83
Assessment of coronary artery disease using coronary computed tomography angiography and biochemical markers. World J Cardiol (2014) 0.83
Autoimmune myocarditis, valvulitis, and cardiomyopathy. Curr Protoc Immunol (2013) 0.83
Staged cardiovascular magnetic resonance for differential diagnosis of troponin T positive patients with low likelihood for acute coronary syndrome. J Cardiovasc Magn Reson (2010) 0.82
Serial and single time-point measurements of cardiac troponin T for prediction of clinical outcomes in patients with acute ST-segment elevation myocardial infarction. Clin Res Cardiol (2008) 0.81
Implications of troponin testing in clinical medicine. Curr Control Trials Cardiovasc Med (2001) 0.81
ECG-Based Detection of Early Myocardial Ischemia in a Computational Model: Impact of Additional Electrodes, Optimal Placement, and a New Feature for ST Deviation. Biomed Res Int (2015) 0.80
Evaluation of clinical utility of serum enzymes and troponin-T in the early stages of acute myocardial infarction. Indian J Clin Biochem (2003) 0.79
Prognostic value of troponin T, myoglobin, and CK-MB mass in patients presenting with chest pain without acute myocardial infarction. Heart (1996) 0.79
Serum protein measurements and the diagnosis of acute myocardial infarction. Circulation (1991) 0.78
Diagnosis of myocardial infarction: integration of serum markers and clinical descriptors using information theory. Yale J Biol Med (2000) 0.78
Cardiac troponin T in children with acute rheumatic carditis. Pediatr Cardiol (2010) 0.78
Is coronary computed tomography angiography a resource sparing strategy in the risk stratification and evaluation of acute chest pain? Results of a randomized controlled trial. Acad Emerg Med (2011) 0.77
Evaluation of heart function with impedance cardiography in acute myocardial infarction patients. Int J Clin Exp Med (2014) 0.77
[Telemetry in the clinical setting]. Herzschrittmacherther Elektrophysiol (2008) 0.77
Identification of troponin I and actin, alpha cardiac muscle 1 as potential biomarkers for hearts of electrically stimulated chickens. Proteome Sci (2012) 0.77
Novel biomarkers for risk stratification and identification of life-threatening cardiovascular disease: troponin and beyond. Curr Cardiol Rev (2012) 0.76
Minor troponin T elevation in patients 6 months after acute myocardial infarction: an observational study. Clin Res Cardiol (2009) 0.75
Acute cardiogenic pulmonary oedema with multiorgan dysfunction--still to learn more about nitrobenzene poisoning. BMJ Case Rep (2011) 0.75
The Importance of Standardization on Analyzing Circulating RNA. Mol Diagn Ther (2016) 0.75
Evaluating a new graphical ordinal logit method (GOLDminer) in the diagnosis of myocardial infarction utilizing clinical features and laboratory data. Yale J Biol Med (2000) 0.75
Coconut Haustorium Maintains Cardiac Integrity and Alleviates Oxidative Stress in Rats Subjected to Isoproterenol-induced Myocardial Infarction. Indian J Pharm Sci (2012) 0.75
Improving the early diagnosis of acute myocardial infarction. Postgrad Med J (1996) 0.75
Biochemical markers in the management of suspected acute myocardial infarction in the emergency department. Emerg Med J (2001) 0.75
Risk stratification in non-ST elevation acute coronary syndromes: Risk scores, biomarkers and clinical judgment. Int J Cardiol Heart Vasc (2015) 0.75
Pharmacokinetic and pharmacodynamic study of doxorubicin in children with cancer: results of a "European Pediatric Oncology Off-patents Medicines Consortium" trial. Cancer Chemother Pharmacol (2016) 0.75
Potential Effect of L-Carnitine on the Prevention of Myocardial Injury after Coronary Artery Bypass Graft Surgery. J Tehran Heart Cent (2015) 0.75
Effect of electrical cardioversion on myocardial cells in patients in intensive care. BMJ (1998) 0.75
Ambient Ionization Mass Spectrometry Measurement of Aminotransferase Activity. J Am Soc Mass Spectrom (2017) 0.75
Do induced tachycardias within the scope of electrophysiological studies lead to elevated plasma troponin I levels? Herzschrittmacherther Elektrophysiol (2011) 0.75
Early, Complete Infarct Vessel Patency: Arriving at a Gold Standard for Future Clinical Investigation in Myocardial Reperfusion. J Thromb Thrombolysis (1997) 0.75
Direct Comparison of Cardiac Myosin-Binding Protein C With Cardiac Troponins for the Early Diagnosis of Acute Myocardial Infarction. Circulation (2017) 0.75
Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med (2001) 9.31
A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med (1996) 6.05
Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization. N Engl J Med (2001) 2.83
Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO) trial. Circulation (2001) 2.34
Increased neutrophil-platelet adhesion in patients with unstable angina. Circulation (1996) 2.20
Ventricular arrhythmias induced by endothelin-1 or by acute ischemia: a comparative analysis using three-dimensional mapping. Cardiovasc Res (2000) 2.01
Activated platelets induce monocyte chemotactic protein-1 secretion and surface expression of intercellular adhesion molecule-1 on endothelial cells. Circulation (1998) 1.95
Platelet function in septic multiple organ dysfunction syndrome. Intensive Care Med (1997) 1.91
Intracellular compartmentation of cardiac troponin T and its release kinetics in patients with reperfused and nonreperfused myocardial infarction. Am J Cardiol (1991) 1.85
Predictive factors of restenosis after coronary stent placement. J Am Coll Cardiol (1997) 1.84
Platelet function in acute myocardial infarction treated with direct angioplasty. Circulation (1996) 1.75
Cardiac troponin T in patients with end-stage renal disease: absence of expression in truncal skeletal muscle. Clin Chem (1998) 1.75
Diabetes mellitus and the clinical and angiographic outcome after coronary stent placement. J Am Coll Cardiol (1998) 1.73
The complete sequence of the human beta-myosin heavy chain gene and a comparative analysis of its product. Genomics (1990) 1.67
Influence of stent design on 1-year outcome after coronary stent placement: a randomized comparison of five stent types in 1,147 unselected patients. Catheter Cardiovasc Interv (2000) 1.65
Vessel size and long-term outcome after coronary stent placement. Circulation (1998) 1.61
Gene expression profiling of human stent-induced neointima by cDNA array analysis of microscopic specimens retrieved by helix cutter atherectomy: Detection of FK506-binding protein 12 upregulation. Circulation (2001) 1.61
Development and characterization of a rapid assay for bedside determinations of cardiac troponin T. Circulation (1995) 1.61
Development and in vitro characterization of a new immunoassay of cardiac troponin T. Clin Chem (1992) 1.59
Improved troponin T ELISA specific for cardiac troponin T isoform: assay development and analytical and clinical validation. Clin Chem (1997) 1.58
Increased risk of restenosis after placement of gold-coated stents: results of a randomized trial comparing gold-coated with uncoated steel stents in patients with coronary artery disease. Circulation (2000) 1.56
Operator volume and outcome of patients undergoing coronary stent placement. J Am Coll Cardiol (1998) 1.56
Comparison of angiography and intravascular ultrasound for the assessment of lumen size after coronary stent placement: impact of dilation pressures. Cathet Cardiovasc Diagn (1997) 1.49
Non-invasive assessment of perioperative myocardial cell damage by circulating cardiac troponin T. Br Heart J (1991) 1.46
Enzyme linked immuno assay of cardiac troponin T for the detection of acute myocardial infarction in patients. J Mol Cell Cardiol (1989) 1.45
S100A1: a regulator of myocardial contractility. Proc Natl Acad Sci U S A (2001) 1.42
Induction of apoptosis in rhabdomyosarcoma cells through down-regulation of PAX proteins. Proc Natl Acad Sci U S A (1996) 1.41
The effect of leukocyte-depleted blood cardioplegia in patients with severe left ventricular dysfunction: a randomized, double-blind study. J Thorac Cardiovasc Surg (2000) 1.40
Myocardial scintigraphy with iodine-123 phenylpentadecanoic acid and thallium-201 in patients with coronary artery disease: a comparative dual-isotope study. Eur J Nucl Med (1992) 1.38
Early recovery of coronary flow reserve after stent implantation as assessed by positron emission tomography. J Am Coll Cardiol (1999) 1.38
Four-year experience with Palmaz-Schatz stenting in coronary angioplasty complicated by dissection with threatened or present vessel closure. Circulation (1994) 1.31
Influence of lesion length on restenosis after coronary stent placement. Am J Cardiol (1999) 1.25
Restenosis after coronary placement of various stent types. Am J Cardiol (2001) 1.24
Intracellular compartmentation of troponin T: release kinetics after global ischemia and calcium paradox in the isolated perfused rat heart. J Mol Cell Cardiol (1995) 1.21
Subtractive cloning and characterization of DRAL, a novel LIM-domain protein down-regulated in rhabdomyosarcoma. DNA Cell Biol (1997) 1.18
Differences in prognostic factors and outcomes between women and men undergoing coronary artery stenting. JAMA (2000) 1.16
Ischemia induces early changes to cytoskeletal and contractile proteins in diseased human myocardium. J Thorac Cardiovasc Surg (1995) 1.12
[Transient pacemaker dysfunction and spontaneous arrhythmias in symptomatic and asymptomatic patients with ventricular demand pacemakers]. Z Kardiol (1996) 1.09
Vitronectin receptor (alpha(v)beta3) mediates platelet adhesion to the luminal aspect of endothelial cells: implications for reperfusion in acute myocardial infarction. Circulation (1997) 1.06
Protective role against restenosis from an interleukin-1 receptor antagonist gene polymorphism in patients treated with coronary stenting. J Am Coll Cardiol (2000) 1.06
Regulation of monocyte procoagulant activity in acute myocardial infarction: role of tissue factor and tissue factor pathway inhibitor-1. Blood (2001) 1.05
Induction of cytokine expression in leukocytes in acute myocardial infarction. J Am Coll Cardiol (1997) 1.03
Long-term mortality benefit with abciximab in patients undergoing percutaneous coronary intervention. J Am Coll Cardiol (2001) 1.03
Dysregulation of monocytic nuclear factor-kappa B by oxidized low-density lipoprotein. Arterioscler Thromb Vasc Biol (1997) 1.01
Time course of restenosis during the first year after emergency coronary stenting. Circulation (1993) 1.01
Generalized coronary arterio-systemic (left ventricular) fistula. Case report and review of literature. Jpn Heart J (1986) 1.01
Acupuncture treatment improves nerve conduction in peripheral neuropathy. Eur J Neurol (2007) 1.00
Platelet activation and coronary stent implantation. Effect of antithrombotic therapy. Circulation (1996) 0.98
Effect of proteasome inhibitors on monocytic IkappaB-alpha and -beta depletion, NF-kappaB activation, and cytokine production. J Leukoc Biol (1998) 0.98
Influence of balloon pressure during stent placement in native coronary arteries on early and late angiographic and clinical outcome: A randomized evaluation of high-pressure inflation. Circulation (1999) 0.98
Effects of magnesium on platelet aggregation and adhesion. Magnesium modulates surface expression of glycoproteins on platelets in vitro and ex vivo. Thromb Haemost (1994) 0.97
Implementation of pharmacotherapy guidelines in heart failure: experience from the German Competence Network Heart Failure. Clin Res Cardiol (2011) 0.96
Plasma levels of NT-pro-BNP in patients with atrial fibrillation before and after electrical cardioversion. Z Kardiol (2005) 0.96
Influence of reperfusion on serum concentrations of cytosolic creatine kinase and structural myosin light chains in acute myocardial infarction. Am J Cardiol (1987) 0.95
Prognostic value of the modified american college of Cardiology/American heart association stenosis morphology classification for long-term angiographic and clinical outcome after coronary stent placement. Circulation (1999) 0.95
Prognostic value of Doppler echocardiographic mitral inflow patterns: implications for risk stratification in patients with chronic congestive heart failure. J Am Coll Cardiol (2001) 0.94
Assessment of reperfusion of the infarct zone after acute myocardial infarction by serial cardiac troponin T measurements in serum. Br Heart J (1994) 0.94
Right ventricular upregulation of the Ca(2+) binding protein S100A1 in chronic pulmonary hypertension. Biochim Biophys Acta (2000) 0.94
Detection of a hypercoagulable state in nonvalvular atrial fibrillation and the effect of anticoagulant therapy. Thromb Haemost (1996) 0.94
Circulating cardiac myosin light chains in patients with angina at rest: identification of a high risk subgroup. J Am Coll Cardiol (1988) 0.93
Non-invasive assessment of infarct reperfusion: the predictive power of the time to peak value of myoglobin, CKMB, and CK in serum. Eur Heart J (1988) 0.93
Procoagulant inflammatory responses of monocytes after direct balloon angioplasty in acute myocardial infarction. Am J Cardiol (1998) 0.92
X-linked dilated cardiomyopathy. Novel mutation of the dystrophin gene. Ann N Y Acad Sci (1995) 0.91
[On the thrombolytic therapy of recent myocardial infarction. 2. Results of electrocardiographic studies]. Dtsch Med Wochenschr (1966) 0.91
[Catecholamines, myofibrillary degeneration of the heart muscle and cardiac troponin T in various types of agony]. Arch Kriminol (1995) 0.91
Frequency and quantity of the parvovirus B19 genome in endomyocardial biopsies from patients with suspected myocarditis or idiopathic left ventricular dysfunction. Z Kardiol (2004) 0.90
Effect of glycoprotein IIb-IIIa receptor antagonism on platelet membrane glycoproteins after coronary stent placement. Thromb Haemost (1998) 0.89
Primary angiosarcoma of the heart. Report of a case and review of the literature. Jpn Heart J (1993) 0.89
Experimental investigations on the antidotal treatment of nifedipine overdosage. J Toxicol Clin Toxicol (1986) 0.89
Determination of left ventricular filling parameters by pulsed Doppler echocardiography: a noninvasive method to predict high filling pressures in patients with coronary artery disease. Am Heart J (1988) 0.88
Clinical and angiographic follow-up after balloon angioplasty with provisional stenting for coronary in-stent restenosis. Catheter Cardiovasc Interv (1999) 0.88
Differential myocardial abundance of collagen type I and type III mRNA in dilated cardiomyopathy: effects of myocardial inflammation. Cardiovasc Res (1998) 0.88
Doppler echocardiographic assessment of left ventricular filling dynamics in patients with coronary heart disease and normal systolic function. Eur Heart J (1988) 0.88
Changes in membrane glycoproteins of circulating platelets after coronary stent implantation. Heart (1996) 0.87
Guideline adherence for pharmacotherapy of chronic systolic heart failure in general practice: a closer look on evidence-based therapy. Clin Res Cardiol (2007) 0.87
Platelet function and platelet-leukocyte adhesion in symptomatic coronary heart disease. Effects of intravenous magnesium. Thromb Res (1996) 0.87
Cardiovascular autonomic neuropathy contributes to left ventricular diastolic dysfunction in subjects with Type 2 diabetes and impaired glucose tolerance undergoing coronary angiography. Diabet Med (2011) 0.87
Adhesion of monocyte very late antigen-4 to endothelial vascular cell adhesion molecule-1 induces interleukin-1beta-dependent expression of interleukin-6 in endothelial cells. Arterioscler Thromb Vasc Biol (2000) 0.87
Alteration in the pharmacokinetic disposition of ciprofloxacin by simultaneous administration of azlocillin. Antimicrob Agents Chemother (1990) 0.87
Emergency coronary stenting for dissection during percutaneous transluminal coronary angioplasty: angiographic follow-up after stenting and after repeat angioplasty of the stented segment. J Am Coll Cardiol (1994) 0.86
Troponin T release after heart transplantation. Br Heart J (1993) 0.86
Experimental treatment of the acute cardiovascular toxicity of caffeine. J Toxicol Clin Toxicol (1999) 0.86
Intercaval block in normal canine hearts : role of the terminal crest. Circulation (2001) 0.86
Micro-array profiling exhibits remarkable intra-individual stability of human platelet micro-RNA. Thromb Haemost (2012) 0.86
Myocardial perfusion scintigraphy to evaluate patients after coronary stent implantation. J Nucl Med (1998) 0.85